PTC Therapeutics (PTCT) Financial Statements & Analysis

PTC Therapeutics (PTCT) Income Statement

PTC Therapeutics reported revenue of $1.73B in fiscal 2025 (fiscal year ended Dec 31, 2025), up 114.5% from $806.78M a year earlier. Net income was $682.64M, a net margin of 39.4%. Gross margin was 97.3% and operating margin 49.5%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $360.52M, up 101.5% from the same quarter a year earlier.

PTC Therapeutics Income Statement Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

PTC Therapeutics, Inc. income statement - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	1.73	0.81	0.94	0.70	0.54	0.38	0.31	0.26	0.19
Cost of Revenue	0.05	0.06	0.07	0.04	0.57	0.02	0.01	0.01	0.00
Gross Profit	1.68	0.75	0.87	0.65	0.51	0.36	0.29	0.25	0.19
Operating Expenses
Research & Development	0.46	0.53	0.67	0.65	0.54	0.48	0.26	0.17	0.12
Selling, General & Administrative	0.35	0.30	0.33	0.33	0.29	0.25	0.20	0.15	0.12
Operating Expenses	0.83	1.05	1.31	1.10	0.88	0.79	0.54	0.35	0.25
Operating Income	0.86	-0.30	-0.44	-0.45	-0.37	-0.43	-0.24	-0.12	-0.06
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.15	0.17	0.13	0.09	-0.09	0.06	0.01	0.01	0.01
Other Income/Expense	-0.01	-0.06	-0.26	-0.14	-0.14	0.03	0.00	-0.01	-0.01
Income
Income Before Tax	0.70	-0.36	-0.70	-0.59	-0.52	-0.40	-0.24	-0.13	-0.08
Income Tax Expense	0.01	0.00	-0.07	-0.03	0.01	0.04	0.01	0.00	0.00
Net Income	0.68	-0.36	-0.63	-0.56	-0.52	-0.44	-0.25	-0.13	-0.08
Net Income - Continuous Operations	0.68	-0.36	-0.63	-0.56	-0.52	-0.44	-0.25	-0.13	-0.08
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	0.89	-0.12	-0.33	-0.37	-0.31	-0.30	-0.20	-0.09	-0.05
EBIT	0.85	-0.20	-0.35	-0.50	-0.37	-	-	-	-
Depreciation & Amortization	0.02	0.08	0.24	0.13	0.06	0.04	0.03	0.03	0.02
Earnings Per Share
Basic EPS	9.00	-5.00	-8.00	-8.00	-7.00	-7.00	-4.00	-3.00	-2.00
Diluted EPS	8.00	-5.00	-8.00	-8.00	-7.00	-7.00	-4.00	-3.00	-2.00
Basic Shares Outstanding	0.08	0.08	0.07	0.07	0.07	0.07	0.06	0.05	0.04
Diluted Shares Outstanding	0.09	0.08	0.07	0.07	0.07	0.07	0.06	0.05	0.04

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About PTC Therapeutics Financial Statements

What was PTC Therapeutics's revenue in fiscal 2025?

PTC Therapeutics reported revenue of $1.73B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 114.5% from $806.78M a year earlier.

Is PTC Therapeutics profitable?

Yes. PTC Therapeutics earned net income of $682.64M in fiscal 2025, a net margin of 39.4%. In fiscal 2024 it lost $363.30M.

What is PTC Therapeutics's operating margin?

PTC Therapeutics's operating income was $856.51M on revenue of $1.73B in fiscal 2025, an operating margin of 49.5%, compared with -37.5% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition